Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Auditor change
|
|
Inhibitor Therapeutics, Inc. (HPPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| MCNULTY JAMES A (See Remarks) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Disposed of 79,627,069 shares
@ $0
Acquired 398,135 shares
@ $0
Acquired 20,101,057 shares
@ $0 |
|
| 05/17/2023 |
4
| Yanez Michelle (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Acquired 796,271 shares
@ $0 |
|
| 01/19/2021 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Acquired 2,240,488 shares
@ $0 |
|
| 12/28/2020 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 125,000 options
@ $0.031, valued at
$3.9k
|
|
| 12/28/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 1,306,452 options
@ $0.031, valued at
$40.5k
|
|
| 12/28/2020 |
4
| Ono Richard Dana (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 754,839 options
@ $0.031, valued at
$23.4k
|
|
| 12/28/2020 |
4
| Peattie Debra (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 580,646 options
@ $0.031, valued at
$18k
|
|
| 12/28/2020 |
4
| VIRCA NICHOLAS J (President and CEO) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 125,000 options
@ $0.031, valued at
$3.9k
|
|
| 12/28/2020 |
4
| Martin Robert Daniel (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 754,839 options
@ $0.031, valued at
$23.4k
|
|
| 09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Acquired 3,189,688 shares
@ $0 |
|
| 03/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Peattie Debra (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.05, valued at
$10.5k
|
|
| 12/02/2019 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Bought 13,500 shares
@ $0.07, valued at
$945 |
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Ono Richard Dana (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 657,895 options
@ $0.076, valued at
$50k
|
|
| 02/05/2019 |
4
| Martin Robert Daniel (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 657,895 options
@ $0.076, valued at
$50k
|
|
| 02/05/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 657,895 options
@ $0.076, valued at
$50k
|
|
| 02/05/2019 |
4
| MAGRAB E. BRENDAN (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 986,842 options
@ $0.076, valued at
$75k
|
|
| 01/24/2019 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Acquired 362,121 shares
@ $0 |
|
| 12/26/2018 |
4
| Martin Robert Daniel (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 shares
@ $0.08, valued at
$4.8k
|
|
| 12/26/2018 |
4
| MAGRAB E. BRENDAN (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 65,000 shares
@ $0.08, valued at
$5.2k
|
|
| 12/19/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Acquired 184,798 shares
@ $0 |
|
| 08/31/2018 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Sold 100,000 shares
@ $0.27, valued at
$27k
|
|
| 07/06/2018 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Bought 2,318,841 convertible preferred
@ $0
Bought 1,739,131 options to buy
@ $0 |
|
| 03/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2018 |
4
| MAGRAB E. BRENDAN (Chairman of the Board) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 345,000 options to buy
@ $0.2722, valued at
$93.9k
|
|
| 03/15/2018 |
4
| Ono Richard Dana (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 253,000 options to buy
@ $0.2722, valued at
$68.9k
Granted 56,000 options
@ $0.2722, valued at
$15.2k
|
|
| 03/15/2018 |
4
| Watson W. Mark (Director) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 253,000 options to buy
@ $0.2722, valued at
$68.9k
Granted 76,000 options
@ $0.2722, valued at
$20.7k
|
|
| 03/15/2018 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 260,000 options
@ $0.2722, valued at
$70.8k
|
|
|
|
|